References
- Chemtob C., Chaumeil J.C., N'Dongo M. Microencapsulation by ethyl-cellulose phase separation: microcapsule characteristics. International Journal of Pharmaceutics 1986; 29: 1–7
- Huang H.-P., Ghebre-Sellassie I. Preparation of microspheres of water-soluble pharmaceuticals. Journal of Microencapsulation 1989; 6: 219–225
- Loftsson T., Brewster M.E., Derendorf H., Bodor N. 2-Hydroxypropyl-β-cyclodextrin: properties and usage in pharmaceutical formulations. Pharmazeutische Zeitung, Wissenschaftsausgabe 1991b; 4/136: 5–10
- Loftsson T., Friòriksdóttir H., Ólafsdóttir B.J., Gudmundsson Ö. Solubilization and stabilization of drugs through cyclodextrin complexation. Acta Pharmaceutica Nordica 1991a; 3: 215–217
- Loftsson T., Ólafsdóttir B.J., Bodor N. The effects of cyclodextrins on transdermal delivery of drugs. European Journal of Pharmaceutics and Biopharmaceutics 1991c; 37: 30–33
- Loftsson T., Ólafsdóttir B.J., Friòriksdóttir H. Comparative study on inclusion complexation of acetylsalicyclic acid, cholecalciferol and melphalan with β- and γ-cyclodextrin and some of their derivatives. Acta Pharmaceutica Nordica 1990; 2: 303–312
- Luzzi L., Palmieri A. An overview of pharmaceutical applications. Biomedical Applications of Microencapsulations, F. Lim. CRC Press, Boca Raton, Florida 1984; 1–17
- Pitha J., Milecki J., Fales H., Pannell L., Uekama K. Hydroxypropyl-β-cyclodextrin: Preparation and characterization; effects on solubility of drugs. International Journal of Pharmaceutics 1986; 29: 73–82
- Rácz I. Drug formulation. Drug Formulation. John Wiley and Sons, Budapest 1989; 364–367